We found that the depletion of hepatic Crtc2 is beneficial in relieving not only hyperglycemia but also improving whole-body energy metabolism in diet-induced obesity (DIO) mouse models by promoting an Fgf21-dependent pathway. The gene discussed is CRTC2; the disease is Hyperglycemia.